Synonymes : levodopa|L-dopa|59-92-7|Dopar|3,4-dihydroxy-L-phenylalanine|3-Hydroxy-L-tyrosine|Bendopa|Larodopa|Levopa|3,4-Dihydroxyphenylalanine|Brocadopa|Cidandopa|Dopaidan|Dopalina|Insulamina|Maipedopa|Dopasol|Eldopal|Eldopar|Pardopa|Prodopa|Syndopa|Helfo-Dopa|(-)-Dopa|Dihydroxy-L-phenylalanine|Deadopa|Dopaflex|3-(3,4-Dihydroxyphenyl)-L-alanine|Doparkine|Dopaston|Dopastral|Eldopatec|Eurodopa|Doparl|Doprin|Veldopa|Dopal-fher|L-3,4-Dihydroxyphenylalanine|(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid|Levodopum|L-o-Hydroxytyrosine|Dopa|Levedopa|Ledopa|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-Tyrosine, 3-hydroxy-|Dopaston SE|L-(o-Dihydroxyphenyl)alanine|Laradopa|Biodopa|Parda|beta-(3,4-Dihydroxyphenyl)-L-alanine|L-(-)-Dopa|3,4-Dihydroxyphenyl-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|L-3-(3,4-Dihydroxyphenyl)alanine|L-3-Hydroxytyrosine|Cerepap|Inbrija|Sobiodopa|Weldopa|Ro 4-6316|beta-(3,4-Dihydroxyphenyl)alanine|L-Dihydroxyphenylalanine|C9H11NO4|Helfo DOPA|L Dopa|(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid|L-O-Dihydroxyphenylalanine|CVT-301|CCRIS 3766|Levodopum [INN-Latin]|CHEBI:15765|L(-)-Dopa|HSDB 3348|alanine, 3-(3,4-dihydroxyphenyl)-, L-|beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine|L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine|dihydroxyphenylalanine|EINECS 200-445-2|Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-|component of Sinemet|NSC 118381|NSC-118381|Dopar (TN)|DTXSID9023209|beta-(3,4-Dihydroxyphenyl)-alpha-alanine|UNII-46627O600J|3,4-Dihydroxyphenylalanine (VAN)|(-)-(3,4-Dihydroxyphenyl)alanine|NSC118381|DOPA, L-|L-.beta.-(3,4-Dihydroxyphenyl)alanine|CHEMBL1009|.beta.-(3,4-Dihydroxyphenyl)-L-alanine|DHIVY COMPONENT LEVODOPA|DTXCID303209|DUOPA COMPONENT LEVODOPA|RYTARY COMPONENT LEVODOPA|46627O600J|L-(3,4-Dihydroxyphenyl)alanine|PARCOPA COMPONENT LEVODOPA|STALEVO COMPONENT LEVODOPA|Levodopa [USAN:INN:BAN:JAN]|CARBILEV COMPONENT LEVODOPA|CORBILTA COMPONENT LEVODOPA|DOPASNAP COMPONENT LEVODOPA|IPX203 COMPONENT LEVODOPA|V-1512|LEVODOPA COMPONENT OF DHIVY|LEVODOPA COMPONENT OF DUOPA|IPX-203 COMPONENT LEVODOPA|LEVODOPA COMPONENT OF RYTARY|LEVODOPA COMPONENT OF PARCOPA|LEVODOPA COMPONENT OF SINEMET|LEVODOPA COMPONENT OF STALEVO|Inbrija (levodopa inhalation powder)|LEVODOPA COMPONENT OF CARBILEV|LEVODOPA COMPONENT OF CORBILTA|LEVODOPA COMPONENT OF DOPASNAP|.beta.-(3,4-Dihydroxyphenyl)alanine|Levodopa [USAN:USP:INN:BAN:JAN]|CAS-59-92-7|Tyrosine, 3-hydroxy-|NCGC00016270-04|L-(3,4-Dihydroxyphenyl)-.alpha.-alanine|MFCD00002598|LEVODOPA (MART.)|LEVODOPA [MART.]|LEVODOPA (EP IMPURITY)|LEVODOPA [EP IMPURITY]|L-dihydroxy-phenylalanine|LEVODOPA (EP MONOGRAPH)|LEVODOPA [EP MONOGRAPH]|LEVODOPA (USP MONOGRAPH)|LEVODOPA [USP MONOGRAPH]|LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA|LEVODOPA COMPONENT OF LEVODOPA/CARBIDOPA/ENTACAPONE ORION|BDBM50130192|3 Hydroxy L tyrosine|WLN: QVYZ1R CQ DQ|SR-01000075384|L-3,4-Dihydrophenylalanine|Dopastone|Dopicar|Prolopa|L 3,4 Dihydroxyphenylalanine|levodopa-|(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate|IV Levodopa|Prestwick_185|Levodopa (Sinemet)|L-DOPA; Levodopa|Madopa (Salt/Mix)|Spectrum_000454|4-dihydroxyphenylalanine|LEVODOPA [HSDB]|LEVODOPA [USAN]|LEVODOPA [INN]|LEVODOPA [JAN]|Carbidopa EP Impurity A|LEVODOPA [MI]|LEVODOPA [VANDF]|Prestwick0_000017|Prestwick1_000017|Prestwick2_000017|Prestwick3_000017|Spectrum2_000496|Spectrum4_000539|Spectrum5_001899|L-Tirosina, 3-hidroxi-|Lopac-D-9628|Levodopa (JP15/USP)|bmse000322|D08HVR|Epitope ID:150927|LEVODOPA [USP-RS]|LEVODOPA [WHO-DD]|LEVODOPA [WHO-IP]|3, 4-Dihydroxyphenylalanine|Alanine,4-dihydroxyphenyl)-|LEVODOPA [EMA EPAR]|Lopac0_000454|SCHEMBL22655|BSPBio_000053|BSPBio_002354|KBioGR_001177|KBioSS_000934|L-4-5-Dihydroxyphenylalanine|MLS000028514|BIDD:GT0158|DivK1c_000452|SPECTRUM2300205|Levodopa (JP17/USP/INN)|SPBio_000391|SPBio_001974|LEVODOPA [ORANGE BOOK]|BPBio1_000059|GTPL3639|b-(3,4-Dihydroxyphenyl)alanine|WLN: QVYZ1R CQ DQ -L|3, 4-Dihydroxy-L-phenylalanine|BDBM60928|HMS501G14|KBio1_000452|KBio2_000934|KBio2_003502|KBio2_006070|Levodopa [USAN:BAN:INN:JAN]|LEVODOPUM [WHO-IP LATIN]|N04BA01|Alanine,4-dihydroxyphenyl)-, L-|L-(3, 4-Dihydroxyphenyl)alanine|NINDS_000452|HMS1568C15|HMS1922J14|HMS2090O08|HMS2093N04|HMS2095C15|HMS2230B04|HMS3261K10|HMS3712C15|Pharmakon1600-02300205|H-Phe{3,4-(OH)2}-OH|HY-N0304|Levodopa;3,4-Dihydroxyphenylalanine|b-(3,4-Dihydroxyphenyl)-L-alanine|Tox21_110338|Tox21_500454|CCG-39571|HB1925|L-3-(3,4-dihydroxy-phenyl)alanine|L-3-(3,4-dihydroxyphenyl)-Alanine|LS-255|NSC759573|PDSP1_001541|PDSP2_001525|s1726|Alanine, 3-(3,4-dihydroxyphenyl)-|Alanine,4-dihydroxyphenyl)-, (-)-|AKOS010396267|b-(3,4-Dihydroxyphenyl)-a-L-alanine|L-b-(3,4-Dihydroxyphenyl)-a-alanine|L-DOPA (3,4-Dihydroxyphenylalanine)|.beta.-(3, 4-Dihydroxyphenyl)alanine|AC-8432|AM82124|CS-1945|DB01235|LP00454|NSC-759573|SDCCGMLS-0066924.P001|SDCCGSBI-0050439.P004|IDI1_000452|NCGC00015384-01|NCGC00016270-01|NCGC00016270-06|NCGC00016270-07|NCGC00016270-09|NCGC00016270-10|NCGC00016270-22|NCGC00093869-04|NCGC00261139-01|AS-13287|BP-12850|SMR000058312|SBI-0050439.P003|(--)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine|BETA-(3,4-DIHYDROPHENYL)-L-ALANINE|D0600|D9628|EU-0100454|EN300-52637|Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-|C00355|D 9628|D00059|D70595|3,4-Dihydroxy-L-phenylalanine, >=98% (TLC)|AB00052418-06|AB00052418-07|AB00052418_08|AB00052418_09|A832543|Q300989|(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoicacid|Q-201294|SR-01000075384-1|SR-01000075384-4|SR-01000075384-6|SR-01000075384-7|(--)-2Amino-3-(3,4-dihydroxyphenyl)propanoic Acid|Levodopa (optimized formulation, Parkinson's disease)|More effective levodopa (Parkinson's disease), Orion|(S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid|F0347-4695|Levodopa, British Pharmacopoeia (BP) Reference Standard|Levodopa, European Pharmacopoeia (EP) Reference Standard|Z756440064|(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa|1E83F927-C221-46AA-B90A-81B33C5F3868|3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%|Levodopa (optimized formulation, Parkinson's disease), Orion|Levodopa, United States Pharmacopeia (USP) Reference Standard|3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R)|Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material|122769-74-8|65170-01-6|L-Methyldopa ; (2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; 3-(3,4-Dihydroxyphenyl)-?-methyl-L-alanine; 3-Hydroxy-a-methyl-L-tyrosine